• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Biovista Personalized Medicine and Diginova to deliver next generation AI-driven doctor/patient support in a deal that can generate over $5 Billion. September 15, 2021
  • Biovista Harnesses New Kinds of Augmented and Artificial Intelligence to Address COVID-19 August 25, 2020
  • Repositioning Safety May 22, 2020
  • Artificial Intelligence firm Biovista repositions four promising therapeutics against COVID-19 April 22, 2020
  • Business Development Agent in Japan February 12, 2020

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

DIHYDROXYPHENYLALANINE

Drugs for Parkinson’s and Alzheimer’s

August 27, 2018Alzheimer's, Nervous System Disorders, Parkinson's, Vizit Graphs
Drugs for Parkinson’s and Alzheimer’s

Find drugs common to both Parkinson’s and Alzheimer’s diseases using Biovista Vizit. Explore the live graph.

Parkinson’s disease and Diabetes Type 2

August 27, 2018Diabetes, Metabolic Disorders, Nervous System Disorders, Parkinson's, Vizit Graphs
Parkinson disease and Diabetes Type 2

Incretin mimetics or GLP-1 receptor agonists are commonly used in Type 2 Diabetes. Recent evidence favors their use for the treatment of Parkinson’s disease. Explore the live graph.

Vizit Graphs Tag Cloud

CASP3 HELICOBACTER PYLORI INTERFERON ALBUMIN INFLAMMATORY RESPONSE CANCER SARS-COV-2 IFNG LACTATE DEHYDROGENASE MYALGIA IL6 IMMUNE RESPONSE AGING COVID-19 NFKB1 IL1B ALZHEIMER'S DISEASE ACE PARKINSON DISEASE APOPTOTIC PROCESS ACE2 CELL PROLIFERATION COAGULATION LISTERIA MONOCYTOGENES PSEUDOMONAS AERUGINOSA COGNITION STAPHYLOCOCCUS AUREUS INSULIN IL2 RHEUMATOID ARTHRITIS AUTOPHAGY RAS ANGIOTENSIN II TMPRSS2 CELL DIFFERENTIATION NEUTROPHILS PD-1 CD4 INFLAMMATION ESCHERICHIA COLI IL10 TNF IMMUNITY CANDIDA ALBICANS METFORMIN

© 2022 Biovista Vizit All Rights Reserved.